The use of prostate-specific membrane antigen (PSMA)-directed applications in modern
prostate cancer management has evolved rapidly over the past few years, helping to …

Prostate cancer (PCa) is a critical global public health issue with its incidence on the rise.
Radiation therapy holds a primary role in PCa treatment; however, radiation resistance has …

Background Prostate cancer is the second most common cancer with a high risk of
biochemical recurrence (BCR) among men. Recently, 5-methylcytosine (m5C) modification …

Background A huge focus is being placed on the development of novel signatures in the
form of new combinatorial regimens to distinguish the neuroendocrine (NE) characteristics …

Abstract Background Both Ductal Adenocarcinoma (DAC) and Intraductal Carcinoma (IDC)
of the prostate are generally associated with aggressive clinical behavior and poor …

Intraductal carcinoma of the prostate (IDC-P) is a rare and unique form of aggressive
prostate carcinoma, which is characterized by an expansile proliferation of malignant …

Background Prostatic ductal adenocarcinoma (DAC) is an aggressive histologic variant of
prostate cancer that often warrants multimodal therapy and poses a significant diagnostic …

Prostate adenocarcinoma (PRAD) is the most common histological subtype of prostate
cancer. Post-treatment biochemical recurrence is a challenging issue. ATAD1 (ATPase …

Prostate MRI is an essential tool in the diagnostic pathway for prostate cancer. However, its
accuracy can be confounded by a spectrum of noncancerous entities with similar …

Background In this study, effective antigens of mRNA vaccine were excavated from the
perspective of ICD, and ICD subtypes of PRAD were further distinguished to establish an …